Drug details
Bevespi Aerosphere (glycopyrrolate and formoterol fumarate inhalation aerosol)
type of Respiratory Inhalant Combos, Beta2 Agonists, COPD Agents, Anticholinergics, Respiratory
Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol is a combination of an anticholinergic and a long-acting beta2-adrenergic agonist (LABA) indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). Bevespi Aerosphere is not indicated for the relief of acute bronchospasm or for the treatment of asthma.
The drug is often used to treat Asthma , Chronic obstructive pulmonary disease .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- itching,
- rash,
- lightheadedness,
- stomach pain,
- chest pain,
- dizziness,
- dry mouth,
- fainting,
- nervousness,
- fruity breath odor,
- eye pain,
- dry skin,
- poor balance,
- palpitations,
- changes in vision,
- muscle cramps or pain,
- pain or difficulty urinating,
- changes in the amount of urine,
- fast or irregular heart beat,
- increased appetite or thirst,
- increased urination, and
- tremor
The following drugs are related to Bevespi Aerosphere, either as a replacement or used together:
- Advair Diskus (fluticasone propionate)
- Proair HFA (albuterol sulfate inhalation aerosol)
- ProAir Respiclick (albuterol sulfate inhalation powder)
- Anoro Ellipta (umeclidinium and vilanterol inhalation powder)
- Arcapta Neohaler (indacaterol inhalation powder)
- Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)
- Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol)
- Symbicort (budesonide and formoterol fumarate dihydrate)
- Pulmicort Respules (budesonide inhalation suspension)
- Cinqair (reslizumab for intravenous infusion)
- Daliresp (roflumilast)
- Singulair (montelukast sodium)
- Yupelri (revefenacin inhalation solution)
- Stiolto Respimat (tiotropium bromide and olodaterol)
- Tezspire (tezepelumab-ekko injection, for subcutaneous use)